Immediate Impact

3 by Nobel laureates 11 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
2023 Standout
From nature to industry: Harnessing enzymes for biocatalysis
2023 StandoutScience
1 intermediate paper

Works of David Bevan being referenced

Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Updated Results from a Phase 1 and Phase 1/2 Extension Study in Patients without Inhibitors
2016
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
2015

Author Peers

Author Last Decade Papers Cites
David Bevan 1353 814 172 526 77 2.9k
Nancy M. Dunbar 1254 628 331 806 100 3.9k
Meghan Delaney 1679 901 289 616 133 4.1k
Rasheed A. Balogun 963 623 417 1002 66 3.6k
Barbara M. Alving 2162 358 636 457 107 4.7k
Georg Stüssi 967 315 92 387 96 2.1k
William E. Hathaway 1565 510 835 356 98 3.4k
Huy P. Pham 734 412 257 603 89 2.2k
W. Keith Hoots 2500 566 192 317 95 4.1k
Maureen M. O’Brien 940 782 296 593 151 3.6k
Anand Padmanabhan 1432 570 295 858 69 3.7k

All Works

Loading papers...

Rankless by CCL
2026